Fundz

Omeza Announces New Tranche Of Funding And Upcoming Q4 Clinical Activities

PRIVATESep 27, 2023

Round Type

Funding Round

SarasotaManufacturingBiotechnologyHealthcareHealth Care

Description

Omeza, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, today announced that it has completed a $6.5 million offering and issuance of Series Seed Preferred Stock. The proceeds of this equity financing will be utilized to support operational activities, including Omeza's three ongoing clinical trials evaluating the ability of Omeza combination therapy to initiate the wound healing process in refractory diabetic ulcers, venous ulcers, and multiple other etiologies.

Who to call at Omeza, and when

A new round usually means Omeza is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Omeza raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Omeza, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Omeza. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Omeza

Location

1610 Northgate Boulevard

Sarasota, Florida, United States

About

Omeza is a commercial-stage regenerative skin and wound-care company that develops marine-based products comprising essential omega fatty acids and hydrolyzed fish collagen infused with cod liver oil. Founded in 2014, the company currently markets three products (Omeza® Collagen Matrix, Omeza® Lidocaine Lavage, and Omeza® Skin Protectant) designed to reduce inflammation, increase tissue proliferation, and support skin remodeling in adults with a range of chronic, non-healing wounds. Omeza is currently conducting three clinical trials in patients with diabetic ulcers, chronic venous leg ulcers, and multiple other etiologies to evaluate the effects of Omeza Combination Therapy versus standard of care on wound healing, pain reduction, quality of life, and additional secondary endpoints. The company is headquartered in Sarasota, Florida, and has research, manufacturing, and analytical facilities located throughout Florida.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Omeza raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsCynthia L. F., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Omeza's next move

See what Strategic adds

Omeza raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.